Board Member
Whitehawk Therapeutics, Inc. (WHWK)Equibles does not estimate personal net worth.
Get an email with a short summary when Whitehawk Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get WHWK alertsDavid Lennon is recorded as Board Member at Whitehawk Therapeutics, Inc. (WHWK) since January 1, 2023 and CEO at Whitehawk Therapeutics, Inc. (WHWK). The newest filing on record that lists David Lennon as CEO and Board Member at Whitehawk Therapeutics, Inc. (WHWK) is dated April 28, 2026. The proxy statement of Whitehawk Therapeutics, Inc. reports total compensation of $3,359,075 for David Lennon in fiscal 2025, including a base salary of $676,504. Disclosed compensation is on record for 3 fiscal years. David Lennon has spoken on 1 earnings call and 1 other investor event across 1 company, most recently for Whitehawk Therapeutics, Inc. on June 4, 2026. Whitehawk Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Whitehawk Therapeutics, Inc. includes Brendan Delaney (CEO, COO and Board Member), David J. Lennon (CEO and Board Member), Neil Desai, Ph.D. (CEO and Board Member) and 7 others.
“I'm currently developing three ADCs with two that have entered the clinic earlier this year. We recently announced a financing of $87.5 million that extends our runway into 2028 as we pursue each of those programs through dose escalation findings in Phase 1.”
“Good morning, everyone, and thank you for joining us today to review our financial and operational results for the second quarter of 2024. I'd also like to take this opportunity to refresh everyone on Aadi's story, where we are today and where we're going in the weeks and months ahead.”
2023-01-01–present
Last confirmed April 28, 2026
Start not stated–present
Last confirmed April 28, 2026
Biotechnology · Healthcare
CEO, Board Member
2023-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Whitehawk Therapeutics, Inc. (WHWK) | President and Chief Executive Officer | $676,504 | $3,359,075 |
| 2024 | Whitehawk Therapeutics, Inc. (WHWK) | President and Chief Executive Officer | $654,400 | $1,012,068 |
| 2023 | Whitehawk Therapeutics, Inc. (WHWK) | President and Chief Executive Officer | $160,000 | $2,135,688 |
